Calmare Therapeutics Discusses Complaint Settlement
Contract Negotiations Progressing at the Suggestion of the Court
FAIRFIELD, Conn.--(BUSINESS WIRE)--
Calmare Therapeutics Incorporated (CTTC) (CTI), the Calmare® pain mitigation company, discusses settlement with GEO-MC, Ltd. The disagreement dates back to the third quarter of 2014.
“Our flagship medical device, the Calmare® Pain Therapy Device, improves the quality of life of chronic neuropathic pain patients’ like no other modality on the market today,” said Calmare Therapeutics President and CEO Conrad Mir. “Legal matters and similar distractions take away from the greater good Calmare Pain Mitigation Therapy™ can bring. We need to turn the page on this matter and get back to what Calmare Therapeutics does best – give chronic pain patients their life back. They deserve our unconditional commitment to this resolution if not more.”
